Zydus Wellness (ZWL) has received approval from the Competition Commission of India (CCI) for the company’s acquisition of Heinz India jointly with Cadila Healthcare. The definitive agreement in relation to this acquisition was signed on October 24, 2018.
ZWL will primarily be acquiring the business related to the four brands - Glucon-D, Nycil, Sampriti and Complan, through this transaction. The CCI approval takes ZWL one step closer to completing the acquisition, which is expected to unlock significant value for ZWL by enriching its portfolio and expanding the reach of its distribution network.
Zydus Wellness is an integrated consumer company. The company is engaged in the development, production, marketing and distribution of health and wellness products.
